Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a publicly traded Healthcare sector company. As of August 26, 2026, CTNM trades at $17.05 with a market cap of $625.64M and a P/E ratio of -7.88. CTNM moved +2.50% today. Year to date, CTNM is +49.69%; over the trailing twelve months it is +64.10%. Its 52-week range spans $3.35 to $17.51. Analyst consensus is strong buy with an average price target of $23.80. Rallies surfaces CTNM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CTNM shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $17.05 |
| Market Cap | $625.64M |
| P/E Ratio | -7.88 |
| EPS | $-2.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.51 |
| 52-Week Low | $3.35 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-59.98M |
| Gross Margin | 0.00% |
6 analysts cover CTNM: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $23.80.